Seminar: The power of NGS and array based studies in Cancer Research
Join us for a review of the latest progress in cancer research, and how Illumina’s portfolio can help you in your studies of cancer. Illumina offers solutions that can rapidly help determine the unique cancer genome, epigenome and transcriptome in each patient. These solutions can help elucidate the mechanisms underlying the disease.
The seminar will consist of presentations by cancer researchers and representatives of Illumina. The topics will cover how to:
- Detect cancer mutations by sequencing of whole genomes, exomes, or targeted gene panels.
- Detect chromosomal rearrangements and copy number variants using microarrays or sequencing.
- Characterise epigenetic changes and DNA-methylation patterns by sequencing or microarrays for methylation analysis.
- Profile differential expression between normal, mutated and fusion transcripts in tumor and normal tissues.
- Determine the role of small and other non-coding RNA’s in cancer biology. Using New Technologies to Study the Genetics of Disease
Friday 4th October, 13.00
Blå Korsets Konferens, Uppsala University Hospital, Entrance 6, Uppsala
- 13:00 Welcome, Ann-Christine Syvänen, Uppsala University
- 13:15 Illumina cancer applications, Pernille Albertus, Illumina
- 13:30 Illumina NGS cancer products Anders Hedström, Illumina
- 13:45 Risk genes, mutations and treatment in breast cancer (Preliminary title), Åke Borg, Lund University
- 14:15 Identification of genes that confer increased risk of colorectal cancer, Annika Lindblom and Vinaykumar Kontham, Karolinska Institutet
- 14:45 Coffee break
- 15:15 Functional genomics of pediatric acute lymphoblastic leukemia, Jessica Nordlund, Uppsala University
- 15:45 Transcriptomic profiling of neuroblastoma tumors, Chandrasekhar Kanduri, Gothenburg University
- 16:15 Molecular dissection of (endocrine) tumours, a translational approach towards precision medicine, Joakim Crona, Uppsala University
Organizers: National Genomics Infrastructure (NGI) facilities at Scilifelab and Illumina